483 related articles for article (PubMed ID: 31348009)
1. Renin-Angiotensin-Aldosterone System-based Antihypertensive Agents and the Risk of Colorectal Cancer Among Medicare Beneficiaries.
Htoo PT; Stürmer T; Jonsson-Funk M; Pate V; Simpson RJ; Lund JL
Epidemiology; 2019 Nov; 30(6):867-875. PubMed ID: 31348009
[TBL] [Abstract][Full Text] [Related]
2. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system.
Sandhu AT; Kohsaka S; Lin S; Woo CY; Goldstein MK; Heidenreich PA
Am Heart J; 2021 Oct; 240():46-57. PubMed ID: 34126079
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
5. Real-World Effectiveness of Beta-Blockers versus Other Antihypertensives in Reducing All-Cause Mortality and Cardiovascular Events.
Foch C; Allignol A; Hostalek U; Boutmy E; Hohenberger T
Int J Clin Pract; 2022; 2022():6124559. PubMed ID: 35989866
[TBL] [Abstract][Full Text] [Related]
6. First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care.
Sinnott SJ; Douglas IJ; Smeeth L; Williamson E; Tomlinson LA
BMJ; 2020 Nov; 371():m4080. PubMed ID: 33208355
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.
Choksi TT; Zhang H; Chen T; Malhotra N
Am J Nephrol; 2021; 52(3):250-260. PubMed ID: 33827074
[TBL] [Abstract][Full Text] [Related]
8. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort.
Lu Y; Van Zandt M; Liu Y; Li J; Wang X; Chen Y; Chen Z; Cho J; Dorajoo SR; Feng M; Hsu MH; Hsu JC; Iqbal U; Jonnagaddala J; Li YC; Liaw ST; Lim HS; Ngiam KY; Nguyen PA; Park RW; Pratt N; Reich C; Rhee SY; Sathappan SMK; Shin SJ; Tan HX; You SC; Zhang X; Krumholz HM; Suchard MA; Xu H
JAMA Netw Open; 2022 Mar; 5(3):e223877. PubMed ID: 35323951
[TBL] [Abstract][Full Text] [Related]
11. Comparison of diagnostic evaluations for cough among initiators of angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
Gokhale M; Girman C; Chen Y; Pate V; Funk MJ; Stürmer T
Pharmacoepidemiol Drug Saf; 2016 May; 25(5):512-20. PubMed ID: 26860956
[TBL] [Abstract][Full Text] [Related]
12. Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network.
Smith SM; Winterstein AG; Gurka MJ; Walsh MG; Keshwani S; Libby AM; Hogan WR; Pepine CJ; Cooper-DeHoff RM
J Am Heart Assoc; 2023 Jan; 12(1):e026652. PubMed ID: 36565195
[TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study.
Shen JI; Saxena AB; Vangala S; Dhaliwal SK; Winkelmayer WC
BMC Nephrol; 2017 Jun; 18(1):196. PubMed ID: 28623899
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers.
Ozawa T; Hashiguchi Y; Yagi T; Fukushima Y; Shimada R; Hayama T; Tsuchiya T; Nozawa K; Iinuma H; Ishihara S; Matsuda K
Int J Colorectal Dis; 2019 Oct; 34(10):1731-1739. PubMed ID: 31478086
[TBL] [Abstract][Full Text] [Related]
15. Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands.
Li X; Bijlsma MJ; Bos JHJ; Schuiling-Veninga CCM; Hak E
BMJ Open; 2023 Aug; 13(8):e068721. PubMed ID: 37558444
[TBL] [Abstract][Full Text] [Related]
16. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
[TBL] [Abstract][Full Text] [Related]
17. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
Trifirò G; Massari M; Da Cas R; Menniti Ippolito F; Sultana J; Crisafulli S; Giorgi Rossi P; Marino M; Zorzi M; Bovo E; Leoni O; Ludergnani M; Spila Alegiani S;
Drug Saf; 2020 Dec; 43(12):1297-1308. PubMed ID: 32852721
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
Huang RS; Cheng YM; Zeng XX; Kim S; Fu P
Chin Med J (Engl); 2016 Mar; 129(5):562-9. PubMed ID: 26904991
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study.
Hsieh YC; Hung CY; Li CH; Liao YC; Huang JL; Lin CH; Wu TJ
Medicine (Baltimore); 2016 May; 95(20):e3721. PubMed ID: 27196491
[TBL] [Abstract][Full Text] [Related]
20. Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer.
Harding BN; Delaney JA; Urban RR; Weiss NS
Gynecol Oncol; 2019 Aug; 154(2):426-431. PubMed ID: 31178150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]